Page 96 - TD-3-1

Tumor Discovery MMP-1 as a potential biomarker for gastric cancer

matrix metallopeptidase-1 genotypes, smoking, alcohol Arch Pharmacol. 2022;395(1):27-38.
drinking and areca chewing to nasopharyngeal Carcinoma doi: 10.1007/s00210-021-02188-x
susceptibility. Anticancer Res. 2016;36(7):3335-3340.
18. Bassiouni W, Ali MAM, Schulz R. Multifunctional
7. Zhao S, Yu M. Identification of MMP1 as a potential
prognostic biomarker and correlating with immune intracellular matrix metalloproteinases: Implications in
infiltrates in cervical squamous cell carcinoma. DNA Cell disease. FEBS J. 2021;288(24):7162-7182.
Biol. 2020;39(2):255-272. doi: 10.1111/febs.15701
doi: 10.1089/dna.2019.5129 19. Kapoor C, Vaidya S, Wadhwan V, Hitesh, Kaur G, Pathak A.
Seesaw of matrix metalloproteinases (MMPs). J Cancer Res
8. Peng Q, Xu Y. Association between promoter polymorphisms
of matrix metalloproteinase-1 and risk of gastric cancer. Ther. 2016;12(1):28-35.
Onco Targets Ther. 2015;8:2519-2526. doi: 10.4103/0973-1482.157337
doi: 10.2147/ott.S83004 20. Jiang H, Li H. Prognostic values of tumoral MMP2 and
9. Scheau C, Badarau IA, Costache R, et al. The role of matrix MMP9 overexpression in breast cancer: A systematic review
metalloproteinases in the epithelial-mesenchymal transition and meta-analysis. BMC Cancer. 2021;21(1):149.
of hepatocellular carcinoma. Anal Cell Pathol (Amst). doi: 10.1186/s12885-021-07860-2
2019;2019:9423907.
21. Shakery T, Safari F. Downregulation of PINKBAR/pAKT
doi: 10.1155/2019/9423907 and MMP2/MMP9 expression in MDA-MB-231 breast
10. Wang X, Khalil RA. Matrix metalloproteinases, vascular cancer cells as potential targets in cancer therapy by hAMSCs
remodeling, and vascular disease. Adv Pharmacol. secretome. Cells Tissues Organs. 2023;212(2):155-163.
2018;81:241-330. doi: 10.1159/000520370
doi: 10.1016/bs.apha.2017.08.002 22. Wang X, Wang B, Xie J, Hou D, Zhang H, Huang H.
11. Moracho N, Learte AIR, Muñoz-Sáez E, et al. Emerging Melatonin inhibits epithelialtomesenchymal transition in
roles of MT-MMPs in embryonic development. Dev Dyn. gastric cancer cells via attenuation of IL1β/NFκB/MMP2/
2022;251(2):240-275. MMP9 signaling. Int J Mol Med. 2018;42(4):2221-2228.
doi: 10.1002/dvdy.398 doi: 10.3892/ijmm.2018.3788
12. Kassiri Z, Khokha R. Myocardial extra-cellular matrix and 23. Rani V, Yadav D, Atale N. Matrixmetalloproteinase
its regulation by metalloproteinases and their inhibitors. inhibitors: Promising therapeutic targets against cancer.
Thromb Haemost. 2005;93(2):212-219. Curr Pharm Des. 2021;27(45):4557-4567.
doi: 10.1160/th04-08-0522 doi: 10.2174/1381612827666210830103059
13. Craig VJ, Zhang L, Hagood JS, Owen CA. Matrix 24. Yang C, Gong A. Integrated bioinformatics analysis for
metalloproteinases as therapeutic targets for idiopathic differentially expressed genes and signaling pathways
pulmonary fibrosis. Am J Respir Cell Mol Biol. 2015;53(5): identification in gastric cancer. Int J Med Sci. 2021;18(3):792-800.
585-600. doi: 10.7150/ijms.47339
doi: 10.1165/rcmb.2015-0020TR 25. Xu J, Changyong E, Yao Y, Ren S, Wang G, Jin H.
14. Grillet B, Pereira RVS, Van Damme J, Abu El-Asrar A, Matrix metalloproteinase expression and molecular
Proost P, Opdenakker G. Matrix metalloproteinases in interaction network analysis in gastric cancer. Oncol Lett.
arthritis: Towards precision medicine. Nat Rev Rheumatol. 2016;12(4):2403-2408.
2023;19(6):363-377. doi: 10.3892/ol.2016.5013
doi: 10.1038/s41584-023-00966-w 26. Cai QW, Li J, Li XQ, Wang JQ, Huang Y. Expression of STAT3,
15. Nissinen L, Kähäri VM. Matrix metalloproteinases in MMP-1 and TIMP-1 in gastric cancer and correlation with
inflammation. Biochim Biophys Acta. 2014;1840(8):2571-2580. pathological features. Mol Med Rep. 2012;5(6):1438-1442.
doi: 10.1016/j.bbagen.2014.03.007 doi: 10.3892/mmr.2012.849
16. Xie J, Zhou X, Wang R, et al. Identification of potential 27. Chen YJ, Liang L, Li J, et al. IRF-2 inhibits gastric cancer
diagnostic biomarkers in MMPs for pancreatic carcinoma. invasion and migration by down-regulating MMP-1. Dig
Medicine (Baltimore). 2021;100(23):e26135. Dis Sci. 2020;65(1):168-177.
doi: 10.1097/md.0000000000026135 doi: 10.1007/s10620-019-05739-8
17. Lopez-Navarro ER, Gutierrez J. Metalloproteinases and their 28. Liu M, Hu Y, Zhang MF, et al. MMP1 promotes tumor
inhibitors in neurological disease. Naunyn Schmiedebergs growth and metastasis in esophageal squamous cell

Volume 3 Issue 1 (2024) 8 https://doi.org/10.36922/td.1973